(Q39040664)

English

Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors

scientific article published on June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Crohn's disease

1 reference

based on heuristic

inferred from title

Saccharomyces cerevisiae

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Boualem Sendid

6

0 references

object named as

Daniel Poulain

9

0 references

Annie Standaert-Vitse

7

object named as

Annie Standaert-Vitse

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Peggy Vandewalle-El Khoury

2

object named as

Peggy Vandewalle

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

8

object named as

Ali Ayadi

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Ines Hadrich

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Fatma Cheikhrouhou

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Fattouma Makni

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Mohamed Salah Krichen

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Scandinavian Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

717-725

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Impact of race and ethnicity on inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

Seroreactivity againstSaccharomyces cerevisiaein patients with Crohn’s disease and celiac disease

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

CARD15/NOD2 in a Tunisian population with Crohn's disease

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

Mother to child transmission of anti-S cerevisiae mannan antibodies (ASCA) in non-IBD families.

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease

1 reference

https://api.crossref.org/works/10.1080%2F00365520601083625

21 January 2018

Identifiers

10.1080/00365520601083625

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39040664&oldid=1874755490"